Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cureus|March 12, 2026
Challenges and Opportunities in Evaluating Novel Drug-Radiotherapy CombinationsShelby Lane, Charles B Simone, Jessica Schuster, et al.
European Urology|August 25, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladderGeorgios Gakis, Jason Efstathiou, Seth P Lerner, et al.
Urologic Oncology|October 11, 2025
PSA density as a dynamic prognostic marker of biopsy grade progression during active surveillanceAndrew Gusev, Florian Rumpf, Dimitar Zlatev, et al.
The Oncologist|April 8, 2016
Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic SettingCarolyn A Brown, Gita Suneja, Neo Tapela, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2018
MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality TreatmentWei Meng, Jason Efstathiou, Rajbir Singh, et al.
The Journal of Urology|February 15, 2019
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based GuidelineScott C Morgan, Karen Hoffman, D Andrew Loblaw, et al.
Practical Radiation Oncology|October 17, 2018
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based GuidelineScott C Morgan, Karen Hoffman, D Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 TrialJohn J Coen, Joseph P Rodgers, Philip J Saylor, et al.
Nature Reviews. Urology|November 30, 2023
Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data SystemValeria Panebianco, Alberto Briganti, Thierry N Boellaard, et al.
JCO Precision Oncology|July 8, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision OncologySophia C Kamran, Monica Borges, Jeff Michalski, et al.
Pageof 4